ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
REVLIMID® Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patien
February 27, 2017Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation announced that the European Commission (EC) has approved REVLIMID® (lenalidomide) as monotherapy for the maintenance treatment of adult patients with newly diagnosed multiple mye -
Rabbit virus proves effective in treatment of multiple myeloma
February 23, 2017A team of researchers at the Medical University of South Carolina (MUSC) utilising the myxoma virus (MYXV) to treat multiple myeloma discovered that the method prompted a strong immune response and eliminated the majority of malignant cells associated wit -
Health Canada approves REVLIMID plus dexamethasone as a first-line treatment for patients newly diag
January 25, 2017Celgene Inc. announced today that Health Canada has expanded the indication for REVLIMID® (lenalidomide capsules), in multiple myeloma.
Pharma Sources Insight January 2025
